Almunajem Foods Company (TADAWUL:4162)
66.50
-1.40 (-2.06%)
Jul 31, 2025, 3:18 PM AST
Sage Therapeutics Balance Sheet
Financials in millions SAR. Fiscal year is January - December.
Millions SAR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2018 - 2020 |
---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2018 - 2020 |
Cash & Equivalents | 37.99 | 42.63 | 248.93 | 111.03 | 85.53 | 19.91 | Upgrade |
Cash & Short-Term Investments | 37.99 | 42.63 | 248.93 | 111.03 | 85.53 | 19.91 | Upgrade |
Cash Growth | -79.08% | -82.88% | 124.20% | 29.82% | 329.64% | -0.92% | Upgrade |
Accounts Receivable | 382.36 | 306.72 | 261.54 | 253.28 | 219.83 | 200.76 | Upgrade |
Other Receivables | 0.73 | 0.65 | 9.27 | 0.94 | 10.53 | 81.92 | Upgrade |
Receivables | 383.09 | 307.37 | 270.81 | 254.22 | 230.36 | 282.68 | Upgrade |
Inventory | 798.78 | 837.78 | 716.74 | 777.25 | 602.78 | 419.99 | Upgrade |
Prepaid Expenses | 22.1 | 16.39 | 13.79 | 12.49 | 9.99 | 7.91 | Upgrade |
Other Current Assets | 29.62 | 12.75 | 5.26 | 8.9 | 31.23 | 7.11 | Upgrade |
Total Current Assets | 1,272 | 1,217 | 1,256 | 1,164 | 959.89 | 737.6 | Upgrade |
Property, Plant & Equipment | 394.44 | 382.62 | 307.71 | 318.94 | 335.17 | 327.98 | Upgrade |
Long-Term Investments | 337.37 | 335.01 | - | - | - | - | Upgrade |
Other Intangible Assets | 2.03 | 1.69 | 1.52 | 1.52 | 2.91 | 4.27 | Upgrade |
Total Assets | 2,005 | 1,936 | 1,565 | 1,484 | 1,298 | 1,070 | Upgrade |
Accounts Payable | 584.55 | 579.71 | 427.36 | 403.76 | 322.25 | 149.78 | Upgrade |
Accrued Expenses | 70.74 | 71.02 | 86.48 | 59.33 | 56.2 | 54.34 | Upgrade |
Short-Term Debt | 92 | 92 | - | - | - | 128 | Upgrade |
Current Portion of Leases | 13.15 | 12.22 | 8.59 | 8.21 | 6.98 | 6.92 | Upgrade |
Current Income Taxes Payable | 16.65 | 12.6 | 19.54 | 18.84 | 14.8 | 5.29 | Upgrade |
Other Current Liabilities | 28.28 | 12.16 | 4.89 | 4.69 | 4.72 | 3.47 | Upgrade |
Total Current Liabilities | 805.38 | 779.7 | 546.87 | 494.82 | 404.95 | 347.79 | Upgrade |
Long-Term Leases | 90.86 | 86.98 | 37.01 | 40.75 | 43.13 | 41.94 | Upgrade |
Total Liabilities | 955.4 | 926.27 | 637.23 | 583.84 | 493.23 | 429.4 | Upgrade |
Common Stock | 600 | 600 | 600 | 600 | 600 | 150 | Upgrade |
Retained Earnings | 456.38 | 416.35 | 332.7 | 305.48 | 210.28 | 44.19 | Upgrade |
Comprehensive Income & Other | -6.38 | -6.38 | -5.17 | -4.97 | -5.55 | 446.26 | Upgrade |
Shareholders' Equity | 1,050 | 1,010 | 927.53 | 900.51 | 804.74 | 640.45 | Upgrade |
Total Liabilities & Equity | 2,005 | 1,936 | 1,565 | 1,484 | 1,298 | 1,070 | Upgrade |
Total Debt | 196.01 | 191.2 | 45.61 | 48.95 | 50.1 | 176.86 | Upgrade |
Net Cash (Debt) | -158.02 | -148.57 | 203.32 | 62.08 | 35.42 | -156.96 | Upgrade |
Net Cash Growth | - | - | 227.54% | 75.24% | - | - | Upgrade |
Net Cash Per Share | -2.63 | -2.48 | 3.39 | 1.03 | 0.66 | -2.93 | Upgrade |
Filing Date Shares Outstanding | 60 | 60 | 60 | 60 | 60 | 15 | Upgrade |
Total Common Shares Outstanding | 60 | 60 | 60 | 60 | 60 | 15 | Upgrade |
Working Capital | 466.19 | 437.22 | 708.66 | 669.07 | 554.94 | 389.81 | Upgrade |
Book Value Per Share | 17.50 | 16.83 | 15.46 | 15.01 | 13.41 | 42.70 | Upgrade |
Tangible Book Value | 1,048 | 1,008 | 926.01 | 898.99 | 801.83 | 636.19 | Upgrade |
Tangible Book Value Per Share | 17.47 | 16.80 | 15.43 | 14.98 | 13.36 | 42.41 | Upgrade |
Land | - | 71.39 | 71.39 | 72.46 | 72.46 | 72.46 | Upgrade |
Buildings | - | 184.05 | 184.06 | 186.66 | 186.29 | 180.51 | Upgrade |
Machinery | - | 308.07 | 285.43 | 280.18 | 277.87 | 259.99 | Upgrade |
Construction In Progress | - | 6.2 | 0.59 | 1.39 | - | 1.57 | Upgrade |
Updated Nov 9, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.